Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

ONYX-015 combination enters phase II; U.S. patent awarded

Oct. 15, 1997

St. Jude researchers discover new role for p53

Oct. 14, 1997

Pharmacia & Upjohn discloses new distamycin derivatives

Oct. 14, 1997

Antiproliferative activity of simvastatin demonstrated against human gliomas

Oct. 13, 1997

Improved efficacy of MEN-10755 related to apoptosis?

Oct. 13, 1997

DUROS leuprolide enters phase III for prostate cancer

Oct. 10, 1997

Demeter BioTechnologies awarded grant for cancer therapeutics program

Oct. 10, 1997

Progress made on MMAC-1 research; Schering-Plough acquires rights to therapies

Oct. 10, 1997

Selective iNOS inhibitor inhibits tumor growth in mice

Oct. 10, 1997

New immunotherapy for metastatic tumors reported

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...